Does adjuvant therapy reduce postmetastatic survival?

被引:12
作者
Fink, M. K.
机构
关键词
METASTATIC BREAST-CANCER; III COLON-CANCER; INDIVIDUAL PATIENT DATA; DE-NOVO; POOLED ANALYSIS; STAGE-II; CHEMOTHERAPY; FLUOROURACIL; CAPECITABINE; OXALIPLATIN;
D O I
10.1093/annonc/mdz159
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1184 / 1188
页数:6
相关论文
共 31 条
[1]   Adjuvant anthracycline therapy as a prognostic factor in metastatic breast cancer [J].
Alba, E ;
Ribelles, N ;
Sevilla, I ;
Rueda, A ;
Alonso, L ;
Marquez, A ;
Ruiz, I ;
Miramón, J .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 66 (01) :33-39
[2]   Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials [J].
Alberro, J. A. ;
Ballester, B. ;
Deulofeu, P. ;
Fabregas, R. ;
Fraile, M. ;
Gubern, J. M. ;
Janer, J. ;
Moral, A. ;
de Pablo, J. L. ;
Penalva, G. ;
Puig, P. ;
Ramos, M. ;
Rojo, R. ;
Santesteban, P. ;
Serra, C. ;
Sola, M. ;
Solarnau, L. ;
Solsona, J. ;
Veloso, E. ;
Vidal, S. ;
Abe, O. ;
Abe, R. ;
Enomoto, K. ;
Kikuchi, K. ;
Koyama, H. ;
Masuda, H. ;
Nomura, Y. ;
Ohashi, Y. ;
Sakai, K. ;
Sugimachi, K. ;
Toi, M. ;
Tominaga, T. ;
Uchino, J. ;
Yoshida, M. ;
Coles, C. E. ;
Haybittle, J. L. ;
Moebus, V. ;
Leonard, C. F. ;
Calais, G. ;
Garaud, P. ;
Collett, V. ;
Davies, C. ;
Delmestri, A. ;
Sayer, J. ;
Harvey, V. J. ;
Holdaway, I. M. ;
Kay, R. G. ;
Mason, B. H. ;
Forbe, J. F. ;
Franci, P. A. .
LANCET ONCOLOGY, 2018, 19 (01) :27-39
[3]   Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial [J].
Andre, Thierry ;
Boni, Corrado ;
Navarro, Matilde ;
Tabernero, Josep ;
Hickish, Tamas ;
Topham, Clare ;
Bonetti, Andrea ;
Clingan, Philip ;
Bridgewater, John ;
Rivera, Fernando ;
de Gramont, Aimery .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) :3109-3116
[4]   Adjuvant Chemotherapy With FOLFOX for Primary Colorectal Cancer Is Associated With Increased Somatic Gene Mutations and Inferior Survival in Patients Undergoing Hepatectomy for Metachronous Liver Metastases [J].
Andreou, Andreas ;
Kopetz, Scott ;
Maru, Dipen M. ;
Chen, Su S. ;
Zimmitti, Giuseppe ;
Brouquet, Antoine ;
Shindoh, Junichi ;
Curley, Steven A. ;
Garrett, Christopher ;
Overman, Michael J. ;
Aloia, Thomas A. ;
Vauthey, Jean-Nicolas .
ANNALS OF SURGERY, 2012, 256 (04) :642-650
[5]   Third consensus on medical treatment of metastatic breast cancer [J].
Beslija, S. ;
Bonneterre, J. ;
Burstein, H. J. ;
Cocquyt, V. ;
Gnant, M. ;
Heinemann, V. ;
Jassem, J. ;
Koestler, W. J. ;
Krainer, M. ;
Menard, S. ;
Petit, T. ;
Petruzelka, L. ;
Possinger, K. ;
Schmid, P. ;
Stadtmauer, E. ;
Stockler, M. ;
Van Belle, S. ;
Vogel, C. ;
Wilcken, N. ;
Wiltschke, C. ;
Zielinski, C. C. ;
Zwierzina, H. .
ANNALS OF ONCOLOGY, 2009, 20 (11) :1771-1785
[6]   RESPONSE TO CHEMOTHERAPY AFTER RELAPSE IN PATIENTS WITH OR WITHOUT PREVIOUS ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER [J].
BONNETERRE, J ;
MERCIER, M .
CANCER TREATMENT REVIEWS, 1993, 19 :21-30
[7]   Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed [J].
den Brok, Wendie D. ;
Speers, Caroline H. ;
Gondara, Lovedeep ;
Baxter, Emily ;
Tyldesley, Scott K. ;
Lohrisch, Caroline A. .
BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (03) :549-556
[8]   Adjuvant Therapy Reduces Rate of Dissemination but Shortens Survival Thereafter [J].
Fink, Michael K. ;
Kleeberg, Ulrich R. ;
Bartels, Stefan .
ONCOLOGIST, 2015, 20 (07) :E23-E23
[9]   Adjuvant Therapy-Related Shortening of Survival (ATRESS): An Underrated Phenomenon [J].
Fink, Michael K. ;
Kleeberg, Ulrich R. ;
Bartels, Stefan .
ONCOLOGIST, 2015, 20 (01) :88-88
[10]   Survival after recurrence of stage I-III breast, colorectal, or lung cancer [J].
Hassett, Michael J. ;
Uno, Hajime ;
Cronin, Angel M. ;
Carroll, Nikki M. ;
Hornbrook, Mark C. ;
Fishman, Paul ;
Ritzwoller, Debra P. .
CANCER EPIDEMIOLOGY, 2017, 49 :186-194